Health Care & Life Sciences » Pharmaceuticals | Pulike Biological Engineering Inc.

Pulike Biological Engineering Inc. | Income Statement

Fiscal year is January-December. All values CNY Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
467,960.40
472,321.30
475,436.90
576,847.50
521,321.50
599,111.90
Cost of Goods Sold (COGS) incl. D&A
140,616.10
137,786.40
146,326.20
184,109.90
188,628.90
221,828.40
Gross Income
327,344.40
334,534.90
329,110.70
392,737.60
332,692.70
377,283.40
SG&A Expense
155,042.30
174,223.30
176,301.90
225,776.00
254,532.10
268,457
EBIT
168,769.30
155,925.80
146,694.10
163,894.70
78,050.60
105,286.40
Non Operating Income/Expense
92.50
201.90
361.80
15,915.40
33,375.00
21,474.90
Interest Expense
202.20
-
50.50
59.30
54.70
442.60
Pretax Income
192,061.90
166,816.40
168,277.20
221,657.40
135,949.60
166,559.30
Income Tax
29,198.20
26,776.70
26,801.50
32,900.20
19,146.90
17,601.50
Equity in Affiliates
1.60
217.30
266.40
755.10
2,616.90
13,342.90
Consolidated Net Income
162,862.10
140,256.90
141,742.20
188,002.10
114,185.90
135,614.80
Net Income
162,862.10
140,256.90
141,742.20
188,002.10
114,185.90
135,614.80
Net Income After Extraordinaries
162,862.10
140,256.90
141,742.20
188,002.10
114,185.90
135,614.80
Net Income Available to Common
162,862.10
140,256.90
141,742.20
188,002.10
114,185.90
135,614.80
EPS (Basic)
0.68
0.59
0.45
0.59
0.35
0.42
Basic Shares Outstanding
320,000.00
320,000.00
320,000.00
320,000.00
323,740.00
321,496
EPS (Diluted)
0.51
0.44
0.44
0.59
0.35
0.42
Diluted Shares Outstanding
320,000.00
320,000.00
320,000.00
320,000.00
323,740.00
321,496
EBITDA
184,603.40
174,568.20
178,598.20
196,424.70
115,407.50
147,196.90
Other Operating Expense
3,532.80
4,385.80
6,114.70
3,067.00
110.00
3,540.10
Non-Operating Interest Income
476.20
1,502.60
7,392.90
20,970.20
24,578.80
33,475.90

About Pulike Biological Engineering

View Profile
Address
No. 15 Zhenghe Road
Luoyang Henan 471000
China
Employees -
Website http://www.pulike.com.cn
Updated 07/08/2019
Pulike Biological Engineering, Inc. engages in the research & development, manufacture and sale of veterinary bio-products. Its products include industrialization products, vaccine products and medicines. The company was founded on January 1, 1995 and is headquartered in Luoyang, China.